Nanorobotics has developed a proprietary technology to target and kill cancer cells promptly via the use of Molecular NanoMachines. These tiny machines (size 1 nm) can kill the cell mechanically by drilling and tunneling through the membrane until disrupting its nucleus. We are bringing a new modality to oncology - Mechanotherapy. Our recent animal studies have shown dramatic reduction of melanoma growth that is highly resistant to immunotherapy. And the great news - our Mechanotherapy treatment is decoupled from any cancer pathogenesis, mutational rate, or tumor microenvironment. Our programmable, light-activated, nanorobots open a revolutionary new area in nanomedicine. https://nanorobotics.tech